Evidence map›Paper›PMID 42793061›Full record

ArticleBiomolecules2026

Nitrogen-Doped Carbon Dot/TiO

Assia Azouaghe, Florence Back, Walid Daoudi, Abdelmalik El Aatiaoui, Céline Spack, Diana Potes Vecini, David Hoogewijs

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Assia AzouagheLaboratory of Molecular Chemistry, Materials and Environment (LCM2E), Department of Chemistry, Faculty of Applied Sciences, University Mohamed I, Nador 60700, Morocco.
Florence BackSection of Medicine, Department of Endocrinology, Metabolism and Cardiovascular System, University of Fribourg, Chemin Du Musée 5, 1700 Fribourg, Switzerland.ORCID 0000-0001-6159-3813
Walid DaoudiLaboratory of Education, Sciences and Techniques, Higher School of Education and Training of Berrechid, Hassan First University, Settat 26100, Morocco.ORCID 0000-0002-6562-0580
Abdelmalik El AatiaouiLaboratory of Molecular Chemistry, Materials and Environment (LCM2E), Department of Chemistry, Faculty of Applied Sciences, University Mohamed I, Nador 60700, Morocco.ORCID 0000-0002-0147-8407
Céline SpackSection of Medicine, Department of Endocrinology, Metabolism and Cardiovascular System, University of Fribourg, Chemin Du Musée 5, 1700 Fribourg, Switzerland.
Diana Potes VeciniDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.ORCID 0009-0001-8949-9631
David HoogewijsSection of Medicine, Department of Endocrinology, Metabolism and Cardiovascular System, University of Fribourg, Chemin Du Musée 5, 1700 Fribourg, Switzerland.ORCID 0000-0001-5547-6004

Funding

Swiss National Science Foundation 10002455Swiss National Science Foundation 207460
6 · The paper itself

Abstract

Photodynamic therapy (PDT) exploits photoactivated materials that generate reactive oxygen species (ROS) to induce selective cancer cell death. Nitrogen-doped carbon dots (N-CDs) have emerged as promising photosensitizers owing to their favorable optical properties, while hybridization with titanium dioxide (TiO

Indexed as

Carbon Quantum DotsNitrogenPhotosensitizing AgentsReactive Oxygen SpeciesTitaniumA549 CellsApoptosisCarbonCell Line, TumorHumansLightPhotochemotherapyCarbonNitrogenPhotosensitizing AgentsReactive Oxygen SpeciesTitaniumtitanium dioxideA549 lung cancer cellscompositesKelly neuroblastoma cellsnitrogen-doped carbon dots (N-CDs)photodynamic therapy (PDT)reactive oxygen species (ROS)

Identifiers

PMID42793061
PMCPMC13604842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.